00:20 , Mar 30, 2018 |  BioCentury  |  Finance

Heading for Hong Kong

Raising substantially more than planned in a pair of oversubscribed venture rounds gives Hua Medicine Ltd. more breathing room as the Shanghai diabetes company readies itself to be among the first biotechs to list in...
00:16 , Jan 26, 2018 |  BioCentury  |  Finance

Weighing exchanges

Hua Medicine Ltd. is weighing the merits of pursuing an IPO in Hong Kong versus the U.S. ahead of the expected launch of lead candidate dorzagliatin in China. The Shanghai company’s financing strategy will be...
01:39 , Jan 13, 2016 |  BC Extra  |  Politics & Policy

Coalition aims for cancer MoonShot

Stakeholders including biopharma companies, academic research centers, community oncologists, payer Independence Blue Cross (Philadelphia, Pa.) and Bank of America Corp. (NYSE:BAC) launched the MoonShot 2020 initiative to test combination therapies in immuno-oncology. The initiative said...
07:00 , Apr 8, 2013 |  BC Week In Review  |  Company News

Immunomedics, Bank of America Corp., Financial Industry Regulatory Authority (FINRA) cancer, autoimmune, diagnostic news

Immunomedics will receive $18 million in a settlement with Bank of America from an arbitration proceeding before FINRA. Immunomedics also agreed to dismiss the proceeding with prejudice, and it and the bank agreed to release...
07:00 , May 21, 2007 |  BC Week In Review  |  Company News

Bruker BioSciences Corp. board of directors update

Bruker BioSciences Corp. (BRKR), Billerica, Mass.   Business: Supply/Service, Proteomics, Computational chemistry/biology   Appointed: Wolf-Dieter Emmerich, a consultant at Erich Netzsch GmbH & Co. Holding KG; Brenda Furlong, managing director and head of fixed income...